The FDA approves a Pfizer booster vaccine for children ages 12-15: shots

A practicing nurse fills a syringe with the Pfizer COVID-19 vaccine at the Beaumont Health offices in Southfield, Mich., On November 5th.

Jeff Kowalsky / AFP via Getty Images


hide caption

change caption

Jeff Kowalsky / AFP via Getty Images


A practicing nurse fills a syringe with the Pfizer COVID-19 vaccine at the Beaumont Health offices in Southfield, Mich., On November 5th.

Jeff Kowalsky / AFP via Getty Images

The Food and Drug Administration has approved the use of a Pfizer-BioNTech booster in young 12 to 15 year olds.

The agency also shortened the time between the completion of the primary vaccination of the Pfizer-BioNTech COVID-19 vaccine and a booster dose to five months from six.

Finally, the FDA approved a third-dose vaccine for immunocompromised children aged 5 to 11 years.

Give a Comment